Kathryn E. Giusti
Fondateur chez The Multiple Myeloma Research Foundation, Inc.
Fortune : 47 816 $ au 31/10/2023
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Melanie I. Nallicheri | F | 56 |
EQRx International, Inc.
 EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | 5 ans |
| Alexis Borisy | M | 52 |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | 5 ans |
| Robert M. Forrester | M | 60 |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | 5 ans |
| Michael Andreini | M | - |
The Multiple Myeloma Research Foundation, Inc.
 The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | 5 ans |
| Paul Berns | M | 57 |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | 4 ans |
| Kenneth Anderson | M | 72 |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | - |
| Anne Quinn Young | F | - |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | - |
| Karen E. Andrews | F | - |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | 26 ans |
| W. LaForge | M | - |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | - |
| Lori Marcus | F | 61 |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT.
Harvard Business School
| 20 ans |
| Richard N. Merkin | M | - |
FasterCures
| - |
| Vincent A. Miller | M | 62 |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | 4 ans |
| Malcolm Salter | M | 84 |
Harvard Business School
| - |
| Margaret Anderson | F | - |
FasterCures
| 4 ans |
| Lindsey Macleod | F | - |
Harvard Business School
| 4 ans |
| Susanna Ling | F | - |
FasterCures
| - |
| Alvin Silk | M | - |
Harvard Business School
| - |
| Curtis Yates Arledge | M | 58 |
Harvard Business School
| 8 ans |
| Tarun Khanna | M | 57 |
Harvard Business School
| 31 ans |
| Yumiko Murakami | F | 59 |
Harvard Business School
| 9 ans |
| Sean T. Klimczak | M | 47 |
Harvard Business School
| - |
| Mia Mends | F | 48 |
Harvard Business School
| - |
| Dante Roscini | M | 64 |
Harvard Business School
| - |
| Vikram Gandhi | M | 61 |
Harvard Business School
| - |
| Naina Lal Kidwai | F | 67 |
Harvard Business School
| - |
| Matt Higgins | M | - |
Harvard Business School
| - |
| Kelsey Ann DeBriyn | F | - |
Harvard Business School
| - |
| Jennifer E. Lum | F | - |
Harvard Business School
| 5 ans |
| Marjorie Lao | F | 50 |
Harvard Business School
| - |
| David Scharfstein | M | 63 |
Harvard Business School
| 21 ans |
| Vikram Swinder Gandhi | M | - |
Harvard Business School
| - |
| Maya Hari | F | 46 |
Harvard Business School
| - |
| Jay Galeota | M | 57 |
Harvard Business School
| - |
| Laila Worrell | F | 56 |
Harvard Business School
| 2 ans |
| Nasser bin Abu Bakar | M | 57 |
Harvard Business School
| - |
| Anita Elberse | M | 51 |
Harvard Business School
| - |
| Boris Groysberg | M | 52 |
Harvard Business School
| - |
| Siak Wei Low | M | - |
Harvard Business School
| - |
| Peter Boyce | M | - |
Harvard Business School
| 4 ans |
| Guhan Subramanian | M | 53 |
Harvard Business School
| - |
| Pippa Tubman Armerdlng | F | 56 |
Harvard Business School
| 7 ans |
| Rana El-Kaliouby | M | 46 |
Harvard Business School
| 3 ans |
| Fritz Foley | M | - |
Harvard Business School
| - |
| Tsedal Neeley | M | 51 |
Harvard Business School
| 17 ans |
| Shashank Singh | M | 48 |
Harvard Business School
| - |
| Shikhar Ghosh | M | 66 |
Harvard Business School
| 16 ans |
| Imogen Mkhize | F | 61 |
Harvard Business School
| - |
| Das Narayandas | M | 63 |
Harvard Business School
| 30 ans |
| William Kirby | M | 72 |
Harvard Business School
| 16 ans |
| Linda Hill | M | 67 |
Harvard Business School
| 40 ans |
| Laurence Simmons | M | 77 |
Harvard Business School
| - |
| Leonard Schlesinger | M | 71 |
Harvard Business School
| 11 ans |
| David Bruce Yoffie | M | 68 |
Harvard Business School
| 43 ans |
| Jamie Dimon | M | 68 |
Harvard Business School
| - |
| Cynthia Ann Montgomery | F | 72 |
Harvard Business School
| 35 ans |
| Lynn Sharp Paine | M | 74 |
Harvard Business School
| 14 ans |
| George Riedel | M | 66 |
Harvard Business School
| - |
| Michael Klowden | M | 79 |
FasterCures
| - |
| Youngme Moon | M | 60 |
Harvard Business School
| 26 ans |
| Benjamin Esty | M | 61 |
Harvard Business School
| 31 ans |
| Nancy F. Koehn | M | 63 |
Harvard Business School
| 35 ans |
| Steven Wheelwright | M | 80 |
Harvard Business School
| - |
| Rebecca M. Henderson | M | 63 |
Harvard Business School
| 15 ans |
| Joshua Harris | M | 59 |
Harvard Business School
| - |
| Robert Steven Kaplan | M | 65 |
Harvard Business School
| 41 ans |
| Michael Robert Milken | M | 78 |
FasterCures
| - |
| J. Cline | M | 64 |
Harvard Business School
| - |
| Stephen Payne Bradley | M | 82 |
Harvard Business School
| 56 ans |
| James Cash | M | 75 |
Harvard Business School
| 48 ans |
| Krishna Palepu | M | 70 |
Harvard Business School
| 41 ans |
| Philip Bilden | M | 59 |
Harvard Business School
| - |
| Hirotaka Takeuchi | M | 77 |
Harvard Business School
| 48 ans |
| Marco Iansiti | M | 61 |
Harvard Business School
| - |
| Mark Schwartz | M | 70 |
Harvard Business School
| - |
| Anne Dias-Griffin | F | 53 |
Harvard Business School
| - |
| Markus Miele | M | 56 |
Harvard Business School
| - |
| Elizabeth Filkin | F | 82 |
Harvard Business School
| - |
| Archie Jones | M | 52 |
Harvard Business School
| - |
| Joseph Fuller | M | 67 |
Harvard Business School
| 12 ans |
| Rohinton Kalifa | M | 62 |
Harvard Business School
| 5 ans |
| Janet J. Kraus | F | - |
Harvard Business School
| - |
| Gail Maderis | F | 66 |
Harvard Business School
| - |
| Douglas Grissom | M | 56 |
Harvard Business School
| - |
| Ralph M. James | M | 70 |
Harvard Business School
| - |
| Andrew Bursky | M | 67 |
Harvard Business School
| - |
| Juan Arena de la Mora | M | 80 |
Harvard Business School
| - |
| Joseph Bower | M | 85 |
Harvard Business School
| 61 ans |
| Bader Almana | M | - |
Harvard Business School
| 3 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| Richard Kogan | M | 81 | 21 ans | |
| Richard de Schutter | M | 83 |
G.D. Searle & Co., Inc.
 G.D. Searle & Co., Inc. Chemicals: SpecialtyProcess Industries G.D. Searle & Co., Inc. is a company that produces a diverse range of chemicals and agricultural products. The company is based in St. Louis, MO. G.D. Searle & Co. was acquired by Monsanto Co. /Old/ on January 01, 1985. | 4 ans |
| Walter Capone | M | 59 |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | - |
| Eli Casdin | M | 51 |
EQRx International, Inc.
EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | 2 ans |
| Sandra Horning | M | 75 | 4 ans | |
| Paul Giusti | M | - |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | - |
| Richard Henriques | M | 68 | 27 ans | |
| Dina Ciarimboli | F | - | 1 ans | |
| Michael Sherman | M | - |
Harvard Business School
| 2 ans |
| Kayin Barclay | M | - |
Harvard Business School
| 2 ans |
| Tauseef Khan | M | - |
Harvard Business School
| 2 ans |
| Melekot Abate | M | - |
Harvard Business School
| 2 ans |
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 100 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Kathryn E. Giusti
- Réseau Personnel
